IIT-TSAI-PANC
Phase II
OPEN TO ACCRUAL
Adaptive Modification of Neoadjuvant Therapy Based on Clinical Response in Patients with Localized Pancreatic Cancer
IIT-TSAI-PANCREAS-TRIAL
Phase II
OPEN TO ACCRUAL
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS SAmples Study